Normal view MARC view ISBD view

A Spilt Head Study of Efficacy of Placebo versus Platelet-rich Plasma Injections in the Treatment of Androgenic Alopecia. [electronic resource]

By:

Kachhawa, Dilip

Contributor(s):

Publication details: Journal of cutaneous and aesthetic surgery Description: 86-89 p. digitalISSN:

0974-2077

Online resources:

Available from publisher's website

In: Journal of cutaneous and aesthetic surgery vol. 10

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase.
by Grompe, M
2 Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
by Grompe, M
3 Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
by Grompe, M
4 The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion.
by Overturf, K
5 In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
by Manning, K
6 Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
by Al-Dhalimy, M
7 Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.
by Grompe, M
8 A TaqI RFLP at the DRD1 locus.
by Litt, M
9 Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells.
by Wang, X
10 Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.
by Overturf, K
11 Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
by Overturf, K
12 A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
by Grompe, M
13 Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
by Overturf, K
14 Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.
by Grompe, M
15 Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.
by Overturf, K
16 Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
by Grompe, M
17 Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.
by Lagasse, E